Study Conduct

hVIVO, Everbridge partner on patient recruitment

Wednesday, December 2, 2015

hVIVO, a U.K.-based provider of human disease models, and Everbridge, a global provider of SaaS-based unified critical communications solutions, are joining forces to offer a next-generation, virtual clinical trial platform that has the potential to transform the trial volunteer experience.

[Read More]

Parexel launches IMPACT CTMS

Wednesday, December 2, 2015

Parexel International, a global biopharmaceutical services provider, has introduced IMPACT Express Clinical Trial Management System (CTMS). IMPACT Express provides a quick-to-implement, cost-effective clinical trial management solution to simplify clinical trial management and monitoring for small to mid-sized biopharmaceutical companies.

[Read More]

GHO Capital acquires Quotient Clinical

Wednesday, December 2, 2015

GHO Capital, a European specialist healthcare investor, has acquired Quotient Clinical, a Nottingham, U.K.-based provider of outsourced, early-stage drug development services to the pharmaceutical industry. Employing more than 280 professionals, Quotient Clinical enables pharmaceutical and biotechnology customers to improve R&D productivity and accelerate drug development timelines.

[Read More]

Top issues facing ClinOps executives

Tuesday, December 1, 2015

Never before have operating conditions for clinical studies been more difficult. Clinical operations groups face growing pressure to get drugs to market faster while improving efficiencies and study quality. Development costs continue to rise. At the same time, the logistics of conducting a clinical trial have become more complex in the increasingly competitive and regulated environment.

[Read More]

ACRES, Ethical to collaborate on eAdjudication

Wednesday, November 25, 2015

Basel, Switzerland-based Ethical, a provider of Centralized Endpoint Adjudication solutions for clinical trials, and the Cambridge, Mass.-based Alliance for Clinical Research Excellence and Safety (ACRES), a multi-sector nonprofit organization building a multi-stakeholder-driven integrated global system for clinical research, have partnered to improve Centralized Endpoint Adjudication—an essential element of drug development.

[Read More]

WCG Foundation to offer ethics training, education

Monday, November 23, 2015

Citing the need to provide advanced training and education in research ethics, extend scholarships for an international fellows program and make institutional review board (IRB) reviews more affordable for patients who are desperate to gain access to experimental treatments, WIRB-Copernicus Group has launched the WCG Foundation, a nonprofit public charity, to pursue those three programs.

[Read More]